FDA Approves COVID-19 Drug for Young Kids

  • by:
  • 03/02/2023

The FDA on Monday granted the first full approval of Gilead’s COVID-19 drug, remdesivir, for treating the illness in children. 

The move comes months after the agency expanded the drug’s emergency use authorization to also include children below 12 years of age. 

Now, children over the age of 28 days will be able to take the drug. 

The approval applies to children who are hospitalized or have mild-to-moderate disease and are at high risk of severe illness, Fox News reports

The FDA’s decision makes the drug the first approved treatment for those under the age of 12. 

Image: by is licensed under
ADVERTISEMENT

Opinion

View All

British schoolchildren more violent due to lockdown–causes developmental delays: BBC study

Nearly one in five teachers at schools across England reported being hit by a student in the past yea...

London features 'Happy Ramadan' lights throughout city over Easter weekend

The lights have drawn criticism from prominent conservatives who insisted that the council ought to s...

Polish foreign minister claims US was aware of Nord Stream pipeline attack but 'did not prevent it'

Radoslaw Sikorski suggested it was done by "someone who had a vested interest in it."...